After being diagnosed with Alzheimer’s disease or another form of dementia, many people relocate, according to a new report.

Local community members recently came together at Essentia Health Plaza at The Lights for this year’s Walk to End ...

Annovis faces financial challenges and questionable efficacy in Alzheimer's and Parkinson's trials, risking poor stock ...

Potomac-based IGC Pharma Inc. Thursday announced enrollment of patients at the Baycrest Academy for Research and Education in ...

A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the ...

A new diagnosis of Alzheimer's or other dementia often spurs a person to move from their home, new research shows.

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

TOLEDO, OH, Oct. 17, 2024—1.4 million people nationwide live with Lewy body dementia (LBD) according to the Lewy Body ...

More than 600 people are expected to unite Saturday at Harris Pavilion in Manassas for the Alzheimer’s Association Walk to ...

A new diagnosis of Alzheimer's or other dementia often spurs a person to move from their home, new research shows.

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...